NexgenRX Inc. (NXG) — Cash Flow-to-Debt Ratio
NexgenRX Inc. (NXG) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CA$880.82K could theoretically repay 0% of its total liabilities (CA$30.91 Million) in one year. See how much free cash does NexgenRX Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NexgenRX Inc. Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for NexgenRX Inc. across 12 annual periods. Also explore NexgenRX Inc. (NXG) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NexgenRX Inc. (2013–2024)
Year-by-year debt coverage analysis for NexgenRX Inc.. For market capitalisation and broader financial context, see how much is NexgenRX Inc. worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | CA$1.15 Million | CA$22.84 Million | ▼ -11.4% |
| 2023 | 0.06x | CA$1.28 Million | CA$22.48 Million | ▼ -10.0% |
| 2022 | 0.06x | CA$1.07 Million | CA$16.90 Million | ▼ -67.5% |
| 2021 | 0.19x | CA$3.82 Million | CA$19.72 Million | ▲ +44.2% |
| 2020 | 0.13x | CA$2.65 Million | CA$19.72 Million | ▲ +148.9% |
| 2019 | 0.05x | CA$1.05 Million | CA$19.35 Million | ▲ +271.1% |
| 2018 | -0.03x | CA$-507.38K | CA$16.07 Million | ▲ +5.4% |
| 2017 | -0.03x | CA$-257.35K | CA$7.71 Million | ▼ -150.5% |
| 2016 | 0.07x | CA$490.96K | CA$7.43 Million | ▲ +1357.2% |
| 2015 | -0.01x | CA$-34.94K | CA$6.64 Million | ▲ +98.9% |
| 2014 | -0.47x | CA$-558.18K | CA$1.18 Million | ▼ -183.8% |
| 2013 | 0.56x | CA$774.08K | CA$1.37 Million | — |